Efficacy and safety of Shen-Qi Paste, a Traditional Chinese Medicine, in dialysis patients with sarcopenia: A randomized, double-blind, placebo-controlled trial
Phytomedicine · 2025
DOI: 10.1016/j.phymed.2025.157190 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Phytomedicine, 2025. Verfasst von Xiaoyan Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Nursing, Zhejiang Chinese Medical University, Hangzhou 310053, Zhejiang, China. Hauptthemen laut MEDLINE: Sarcopenia, Drugs, Chinese Herbal, Renal Dialysis. Die Arbeit nennt 58 Literaturangaben. Gefördert von: Zhejiang Chinese Medical University, Zhejiang Province Natural Science Foundation.
Abstract (Originalsprache)
BACKGROUND: The lack of effective treatments for sarcopenia remains a major unmet medical need. Shen-Qi Paste (SQP), a Traditional Chinese Medicine (TCM) dietary formulation developed on the basis of the theory of "same origin of medicine and food," offers a novel therapeutic strategy. Unlike conventional approaches that are focused solely on nutrition and exercise, SQP targets the underlying TCM-defined etiologies (e.g., spleen-kidney deficiency) to address the root causes of muscle wasting. Studies have shown that the traditional herbal ingredients of SQP has anti-inflammatory, antioxidant, and muscle protein inhibition properties and can enhance muscle mass and strength. HYPOTHESIS/PURPOSE: This study aimed to assess the efficacy and safety of SQP in dialysis patients with sarcopenia by using a two-center, randomized, double-blind, placebo-controlled clinical trial. METHODS: A total of 128 dialysis patients (age: 45-89 years old) with sarcopenia (as identified by the Asian Sarcopenia Group for Sarcopenia 2019) were randomly allocated to either the SQP group or control group for intervention. Patients in the SQP group and control group were respectively administered oral SQP and placebo at 1 vial/15 g twice daily for 12 weeks. At the same time, all participants maintained low-intensity exercise for 20-30 min/d at a frequency of 3-4 d/wk during the trial. The indexes and scales were examined and evaluated before and after the intervention. The primary indicators were changes in sarcopenia measures, including skeletal muscle mass index (SMI), grip strength, and physical function by five-times sit-to-stand test (FTSST). RESULTS: A total of 163 patients aged 45-89 years were screened, and 128 patients were randomized to receive the study intervention. Some patients (SQP group, n = 6; control group, n = 5) stopped the intervention because of various reasons. A total of 117 patients (55.56 % of whom were male) completed the 12 weeks intervention. The statistical results of the study were as follows: (1) Intra-group comparison: compared to pre-intervention, SQP intervention significantly improved SMI (t, -0.248, [95 %CI, -0.37 to -0.127], p 0.05). CONCLUSION: SQP has the potential to notably enhance muscle mass; therefore, it could be a viable option for treating sarcopenia. Further research should investigate its effectiveness in a broader group of patients and delve into its mechanism of action to offer more detailed evidence for SQP in treating sarcopenia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Nursing, Zhejiang Chinese Medical University, Hangzhou 310053, Zhejiang, China.
- Academy of Chinese Medical Science, Zhejiang Chinese Medical University, Hangzhou 310053, Zhejiang, China.
- Hangzhou Hospital of Traditional Chinese Medicine blood purification center, Hangzhou 310053, Zhejiang, China.
- Xiaoshan District first People's Hospital blood purification center, Hangzhou 310053, Zhejiang, China.
- School of Nursing, Zhejiang Chinese Medical University, Hangzhou 310053, Zhejiang, China. Electronic address: sunqiuhua@zcmu.edu.cn.
Förderung
- Zhejiang Chinese Medical University
- Zhejiang Province Natural Science Foundation
Zitieren
APA
Li, X., Wang, R., Lu, K., He, L., Li, L., Yong, R., Liu, T., Hua, L., Hou, Z., & Sun, Q. (2025). Efficacy and safety of Shen-Qi Paste, a Traditional Chinese Medicine, in dialysis patients with sarcopenia: A randomized, double-blind, placebo-controlled trial. Phytomedicine. https://doi.org/10.1016/j.phymed.2025.157190
Vancouver
Li X, Wang R, Lu K, He L, Li L, Yong R, et al. Efficacy and safety of Shen-Qi Paste, a Traditional Chinese Medicine, in dialysis patients with sarcopenia: A randomized, double-blind, placebo-controlled trial. Phytomedicine. 2025. doi:10.1016/j.phymed.2025.157190
BibTeX
@article{Li2025,
author = {Li, Xiaoyan and Wang, Rongyun and Lu, Keda and He, Luchen and Li, Lin and Yong, Rulin and Liu, Ting and Hua, Lijiangshan and Hou, Zhuoer and Sun, Qiuhua},
title = {Efficacy and safety of Shen-Qi Paste, a Traditional Chinese Medicine, in dialysis patients with sarcopenia: A randomized, double-blind, placebo-controlled trial},
journal = {Phytomedicine},
year = {2025},
doi = {10.1016/j.phymed.2025.157190}
}
EUVIMED